AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On August 1, 2025,
(ARM) closed with a 2.68% decline, trading volume of $1.06 billion—a 67.38% drop from the prior day—ranking it 103rd in market volume. The stock’s performance followed a mixed earnings report and analyst adjustments.Arm reported Q1 fiscal 2026 results, showing 12% year-over-year revenue growth to $1.05 billion, driven by a 25% surge in royalty income to $585 million. However, licensing revenue fell 1% to $468 million. Adjusted net income dropped to $374 million ($0.35/share) from $419 million in the prior year, meeting profit estimates but falling short of revenue forecasts of $1.06 billion. Management projected Q2 revenue of $1.01–$1.11 billion, suggesting stagnation or a decline compared to Q1, with adjusted earnings of $0.29–$0.37.
Analyst reactions were bearish despite mixed initial responses. UBS cut its price target to $175 from $185, while
reduced its target to $180 from $194, both maintaining buy ratings. These adjustments amplified investor concerns about near-term growth and profitability, contributing to the stock’s decline.A backtest of a strategy purchasing the top 500 high-volume stocks daily and holding for one day showed a 166.71% return from 2022 to present, outperforming the benchmark by 137.53%. The strategy’s success underscores the role of liquidity concentration in short-term performance, though it also highlights risks tied to volatility and abrupt market shifts.

Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Dec.24 2025

Dec.24 2025

Dec.23 2025

Dec.23 2025

Dec.23 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet